
| Ingredients | SS-31 (Elamipretide) — D-Arg-Dmt-Lys-Phe-NH2, mitochondria-targeted tetrapeptide |
|---|---|
| Storage | Sealed, protected from light, refrigerated at 2-8°C; avoid freezing |
| Shelf life | 24 months |
| SKU | Content - Spec | Pack | Price | Stock |
|---|---|---|---|---|
| 2S10 | 10mg | 10 vials | $98.00 | In stock |
| 2S50 | 50mg | 10 vials | $409.00 | In stock |
Research reagents are for laboratory and in-vitro research only. Not for human use.
Research reagents are not supplied as medicines and must not be used for diagnosis, treatment, prevention, clinical procedures or self-medication. Product information must not be used as administration or dosing guidance.
For accessories and consumables, follow their own specifications and documented intended use.
SS-31 (Elamipretide) is a mitochondria-targeting peptide that binds to cardiolipin to improve mitochondrial energy production, stabilize cellular respiration, reduce oxidative stress at the source, and protect heart, muscle, brain, and kidney function, with clinical research supporting its role in mitochondrial dysfunction, cardiac protection, anti-aging, and exercise performance.
Improves mitochondrial function; enhances cellular energy metabolism; reduces oxidative stress damage; delays cellular senescence; promotes tissue repair and regeneration
Subcutaneous or intravenous injection; recommended dose 0.5-1 mg/kg body weight, 1-2 times per week, with 4-8 consecutive weeks as one treatment cycle; the specific dose should be adjusted according to individual conditions
Patients with mitochondrial dysfunction-related disorders; individuals seeking anti-aging treatment; patients with chronic fatigue syndrome; adjunctive therapy for neurodegenerative diseases